230 related articles for article (PubMed ID: 24882347)
1. Lobular neoplasia.
King TA; Reis-Filho JS
Surg Oncol Clin N Am; 2014 Jul; 23(3):487-503. PubMed ID: 24882347
[TBL] [Abstract][Full Text] [Related]
2. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.
Simpson PT; Gale T; Fulford LG; Reis-Filho JS; Lakhani SR
Breast Cancer Res; 2003; 5(5):258-62. PubMed ID: 12927036
[TBL] [Abstract][Full Text] [Related]
3. Lobular neoplasia: morphology and management.
Jorns J; Sabel MS; Pang JC
Arch Pathol Lab Med; 2014 Oct; 138(10):1344-9. PubMed ID: 25268198
[TBL] [Abstract][Full Text] [Related]
4. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
Lewis JL; Lee DY; Tartter PI
Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
[TBL] [Abstract][Full Text] [Related]
5. [Ductal and lobular preneoplasia: role in breast cancer development].
Aulmann S
Pathologe; 2011 Nov; 32 Suppl 2():316-20. PubMed ID: 21915665
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.
Mastracci TL; Tjan S; Bane AL; O'Malley FP; Andrulis IL
Mod Pathol; 2005 Jun; 18(6):741-51. PubMed ID: 15696125
[TBL] [Abstract][Full Text] [Related]
7. Lobular carcinoma, not only a classic.
Brogi E; Murray MP; Corben AD
Breast J; 2010; 16 Suppl 1():S10-4. PubMed ID: 21050299
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
[TBL] [Abstract][Full Text] [Related]
9. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
Dauplat MM; Penault-Llorca F
Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for women with lobular carcinoma in situ (LCIS).
Oppong BA; King TA
Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
[TBL] [Abstract][Full Text] [Related]
11. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS
Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937
[TBL] [Abstract][Full Text] [Related]
12. Lobular Neoplasia.
Lunt L; Coogan A; Perez CB
Surg Clin North Am; 2022 Dec; 102(6):947-963. PubMed ID: 36335930
[TBL] [Abstract][Full Text] [Related]
13. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
[TBL] [Abstract][Full Text] [Related]
14. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases.
Wagner PL; Kitabayashi N; Chen YT; Shin SJ
Am J Clin Pathol; 2009 Dec; 132(6):871-6. PubMed ID: 19926578
[TBL] [Abstract][Full Text] [Related]
15. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
[TBL] [Abstract][Full Text] [Related]
16. Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ.
Clauser P; Marino MA; Baltzer PA; Bazzocchi M; Zuiani C
Expert Rev Anticancer Ther; 2016; 16(3):335-46. PubMed ID: 26780850
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
[TBL] [Abstract][Full Text] [Related]
18. [Breast lobular carcinoma in situ: diagnosis and evolution].
Espié M; Hocini H; Cuvier C; Giacchetti S; Bourstyn E; de Roquancourt A
Gynecol Obstet Fertil; 2005 Dec; 33(12):964-9. PubMed ID: 16324870
[TBL] [Abstract][Full Text] [Related]
19. Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast.
Morandi L; Marucci G; Foschini MP; Cattani MG; Pession A; Riva C; Eusebi V
Virchows Arch; 2006 Jul; 449(1):14-23. PubMed ID: 16612623
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.
Reis-Filho JS; Simpson PT; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Valgeirsson H; Lambros M; Ashworth A; Palacios J; Schmitt F; Lakhani SR
J Pathol; 2005 Sep; 207(1):1-13. PubMed ID: 15957152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
